|4Jun 15, 4:56 PM ET

Actinium Pharmaceuticals, Inc. 4

4 · Actinium Pharmaceuticals, Inc. · Filed Jun 15, 2017

Insider Transaction Report

Form 4
Period: 2017-06-15
Berger Mark Stanley
Chief Medical Officer
Transactions
  • Purchase

    Common stock

    2017-06-15$1.11/sh+5,000$5,5505,000 total

Documents

1 file
  • 4
    f4061517berger_actinium.xmlPrimary

    OWNERSHIP DOCUMENT